Inagaki N

References (2)

Title : Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations - Ceriello_2017_J.Diabetes.Investig_8_19
Author(s) : Ceriello A , Inagaki N
Ref : J Diabetes Investig , 8 :19 , 2017
Abstract :
PubMedSearch : Ceriello_2017_J.Diabetes.Investig_8_19
PubMedID: 27180612

Title : SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125
Author(s) : Inagaki N , Onouchi H , Sano H , Funao N , Kuroda S , Kaku K
Ref : Lancet Diabetes Endocrinol , 2 :125 , 2014
Abstract :
PubMedSearch : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125
PubMedID: 24622716